These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297 [TBL] [Abstract][Full Text] [Related]
9. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin. Tomida D; Nishiguchi KM; Kataoka K; Yasuma TR; Iwata E; Uetani R; Kachi S; Terasaki H Invest Ophthalmol Vis Sci; 2011 May; 52(6):3193-9. PubMed ID: 21296829 [TBL] [Abstract][Full Text] [Related]
10. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist. Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125 [TBL] [Abstract][Full Text] [Related]
11. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Fukuhara J; Noda K; Murata M; Namba S; Kinoshita S; Dong Z; Ando R; Lennikov A; Kanda A; Ishida S Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):274-9. PubMed ID: 23233257 [TBL] [Abstract][Full Text] [Related]
12. Suppression of experimental choroidal neovascularization by curcumin in mice. Xie P; Zhang W; Yuan S; Chen Z; Yang Q; Yuan D; Wang F; Liu Q PLoS One; 2012; 7(12):e53329. PubMed ID: 23285282 [TBL] [Abstract][Full Text] [Related]
13. (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Satofuka S; Ichihara A; Nagai N; Noda K; Ozawa Y; Fukamizu A; Tsubota K; Itoh H; Oike Y; Ishida S Am J Pathol; 2008 Dec; 173(6):1911-8. PubMed ID: 18974301 [TBL] [Abstract][Full Text] [Related]
14. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system. Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395 [TBL] [Abstract][Full Text] [Related]
16. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling. Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605 [TBL] [Abstract][Full Text] [Related]
17. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA. Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283 [TBL] [Abstract][Full Text] [Related]
19. Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets. Masuda T; Shimazawa M; Takata S; Nakamura S; Tsuruma K; Hara H Exp Eye Res; 2016 May; 146():196-205. PubMed ID: 27018216 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Gu L; Chen H; Tuo J; Gao X; Chen L Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]